- Filed
- Aug 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 6, 2025 | 306.23M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 299.09M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 296.14M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 291.49M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 291.05M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $377K |
| Capex | Q2 2025 · Jun 30, 2025 | $4.65M |
| Capex restated | Q2 2025 · Jun 30, 2024 | $4.09M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $10.82M |
| Operating Cash Flow restated | Q2 2025 · Jun 30, 2024 | $26.14M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $212.06M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $204.55M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $992K |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $1.73M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $26.67M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $26.38M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $118.39M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $165.11M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $176.82M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $226.15M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $232.11M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $240.74M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $91.66M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $91.05M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $453.62M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $430.42M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $133.08M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $176.89M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $572.01M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $607.23M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.17 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.22 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.03 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.09 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.17 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.22 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.03 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.09 |
| Net Income | Q2 2025 · Jun 30, 2025 | −$48.11M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$60.38M |
| Net Income | Q2 2025 · Mar 31, 2025 | −$12.27M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$6.24M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$21.09M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$14.85M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $10.97M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $23.21M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | $10.64M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | $20M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $33.24M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $67.92M |
| Gross Profit restated | Q2 2025 · Jun 30, 2024 | $33.36M |
| Gross Profit restated | Q2 2025 · Jun 30, 2024 | $67.53M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $31.77M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $61.39M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $33.84M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $68.94M |
| Revenue | Q2 2025 · Jun 30, 2025 | $65.01M |
| Revenue | Q2 2025 · Jun 30, 2025 | $129.31M |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $67.2M |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $136.47M |